OpenAlex · Aktualisierung stündlich · Letzte Aktualisierung: 09.04.2026, 19:43

Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.

S1401 Personalizing Hepatology: The Role of Chatbots in Tailored Treatment Plans in the Field of Hepatology

2023·0 Zitationen·The American Journal of Gastroenterology
Volltext beim Verlag öffnen

0

Zitationen

8

Autoren

2023

Jahr

Abstract

Introduction: Chatbot’s like ChatGPT and Google Bard have significantly impacted healthcare, particularly hepatology, enhancing liver disease diagnosis and treatment. These advanced solutions interpret ultrasound images, analyze various samples, streamline administrative tasks, and aid in medical imaging and device automation. By enabling personalized treatments and side-effect predictions, they have considerably improved hepatology disorder management. Integrating these AI tools provides patients with tailored treatment evaluations, promoting informed decision-making. However, the effectiveness of these chatbots still warrants further scrutiny. Methods: The study set out to evaluate the precision of 2 prominent Chat Bots - Chat GPT and Google BARD - in addressing medical management queries. Both bots were tasked with a series of questions, and their responses were evaluated on a 1-10 Likert scale, with 1 indicating utmost accuracy. Two unbiased evaluators examined each bot's responses to ensure objective evaluation. The research aimed to provide insight into these Chat Bots' capabilities via a structured performance appraisal, focusing on accuracy and dependability. The dual-evaluator system and the Likert scale approach helped minimize possible bias, thereby lending credibility to the findings. Results: Our research contrasted the effectiveness of Chat GPT and Google BARD in the realm of liver disease management. Chat GPT excelled, scoring 74% in the accuracy of information compared to Google BARD's 49% (P = 0.015) and 48% vs29% in medical information reliability (P = 0.032). This study emphasizes the critical role of accuracy, and dependability, in developing liver disease-oriented chatbots. While Chat GPT displayed impressive performance, indicating its potential as a reliable tool, it also underscored the necessity for continued research and development in this field. Conclusion: This research revealed the relative strengths of Chat GPT and Google Bard in liver disease management, with Chat GPT outperforming in both accuracy and reliability. As AI technologies continue to permeate healthcare, ensuring their accuracy is crucial. While Chat GPT demonstrated promising potential as a reliable hepatology tool, it also highlighted the continuous need for research and development in this domain. The significant disparity in performance emphasizes the importance of rigorous testing and validation before integrating AI tools into medical practice (Figure 1, Table 1).Figure 1.: Chatbots Liver Management example. Table 1. - Chatbot study outcome Chat Bot questions ChatGPT (Likert scale 1-10, 1 being low and 10 being high) Google BARD (Likert scale 1-10, 1 being low and 10 being high) P - Value Write the management for hepatitis C 7.1 4.1 P=0.021 How do you treat liver cancer? 5.9 3.9 P< 0.01 What's the dosage for hepatitis medication? 6.9 4.4 P = 0.0025 How do you treat fatty liver? 9.1 5.9 P = 0.035 What is the management for fibronodular hyperplasia? 8.9 6.1 P < 0.05

Ähnliche Arbeiten